Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Alzheimers Dement. 2021 Sep 5;18(4):551–560. doi: 10.1002/alz.12429

TABLE 2.

Participant measures by race

African-American White P
n (%) 79 (49.7) 80 (50.3)
Age, Exam 1, M (SD) 55.8 (6.8) 55.7 (6.5) .945
Age, Exam 6, M (SD) 71.5 (6.7) 71.8 (6.6) .810
Sex (M/F) 50/29 38/42 .045*
Years of education, M (SD) 14.9 (2.7) 15.1 (2.8) .729
aCognitive status .618
 Normal, n (%) 49 (62.8) 57 (72.2)
 MCI, n (%) 24 (30.8) 18 (22.8)
 Dementia, n (%) 3 (3.9) 3 (3.8)
APOE-ε4, (+/−/missing) 31/45/3 22/55/3 .283
% ASCVD, M (SD) 8.76 (6.8) 5.45 (4.5) <.001*
b% FSRP, M (SD) 2.33 (2.4) 1.78 (1.8) .096
CAIDE, M (SD) 7.25 (2.3) 6.55 (2.2) .051
SBP, M (SD) 133.0 (21.9) 121.0 (17.4) <.001*
DBP, M (SD) 75.7 (9.2) 71.9 (11.0) .020*
cCASI Exam 5, M (SD) 89.7 (6.2) 94.6 (3.7) <.001*
dCASI Exam 6, M (SD) 90.6 (7.2) 94.3 (4.8) <.001*
eCASI change (5 to 6), M (SD) 0.8 (6.8) −0.4 (4.9) .224
PiB SUVR, M (SD) 1.27 (0.28) 1.39 (0.37) .029*
Aβ+, n (%) 25 (31.7) 32 (40.0) .272
fWMH vol. (% ICV), median (IQR) 0.21 (0.11, 0.55) 0.23 (0.10, 0.55) .979
dCort. Thick., mm, M (SD) 2.66 (0.13) 2.69 (0.12) .143

Abbreviations: Aβ, β-amyloid; ASCVD, atherosclerotic cardiovascular disease risk estimate from the pooled cohort equation; FSRP, Framingham stroke risk profile; CAIDE, cardiovascular risk factors, aging, and incidence of dementia risk score; SBP, systolic blood pressure; DBP, diastolic blood pressure; CASI, Cognitive Abilities Screening Instrument; PiB SUVR, Pittsburgh compound B Standardized Uptake Value Ratio; Cort. thick., Cortical thickness; WMH vol., white matter hyperintensity volume; ICV, intracranial volume.

*

Statistically significant at P < .05

a

White n = 78; African-American n = 76.

b

White n = 80; African-American n = 78.

c

White n = 80; African-American n = 76.

d

White n = 79; African-American n = 79.

e

White n = 79; African-American n = 76.

f

White n = 79; African-American n = 78.